Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures
Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures, with participation from Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar and other private backers. Assets will be contributed to increase ZenOnco.io’s current operation

Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures, with participation from Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar and other private backers.
Assets will be contributed to increase ZenOnco.io’s current operations and dispatch new items, said the organization in a public statement.
Established in 2019 by Dimple Parmar and Kishan Shah, ZenOnco.io expects to work on personal satisfaction and expand life for disease patients through integrative oncology therapy, which incorporates clinical treatment just as correlative treatment.
The platform has a group of onco-nutritionists, onco-therapists and physiotherapists to assist disease patients with secondary effects and indication the board to work on their personal satisfaction.
As per the Bengaluru-settled organization, it has collaborated with 200 emergency clinics, 1,500 oncologists, 200 analytic labs across India to give clinical treatment and have contacted in excess of 80,000 day to day routines and guided more than 20,000 lives.
Reader questions.
About “Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures” — five of the most-asked, in the desk's own words.
01What is this story about?
Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures, with participation from Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar and other private backers. Assets will be contributed to increase ZenOnco.io’s current operation02Who wrote it?
Sheena · Staff. 1 min read · May 14, 2026.03Is this sponsored?
If a piece is, the disclosure sits above the cover image and again in our public transparency report. This one carries no commercial disclosure.04How do I get the rest?
Subscribe to The Briefing for a Wednesday letter from the desk, or browse by category from the top navigation.



